Guidelines
Guidelines
Don’t discontinue osteoporosis meds for COVID-19 vaccines, expert guidance says
Recommendations help physicians distinguish between a reaction to the vaccine and a reaction to medication.
Guidelines
Updated ACC decision pathway embraces new heart failure treatment strategies
The ACC’s updated decision pathway aims to close the substantial gap between current practice and unmet opportunities for inhibiting HFrEF...
Guidelines
Large study links brown fat with lower rates of cardiometabolic disease
Research in over 50,000 individuals shows those with brown fat seemed to have lower risks of diabetes and cardiovascular disease than those with...
From the Journals
AGA Clinical Practice Update: How diet and exercise can help manage NAFLD
NAFLD affects approximately 25% of individuals worldwide, but medication, bariatric endoscopy, and surgery are reserved for only a small subset....
Guidelines
ADA 2021 standards address financial hardship in diabetes
In the year of COVID-19, new ADA standards include assessment of socioeconomic challenges, individualization of type 2 diabetes treatment, and...
From the Journals
New AHA scientific statement on menopause and CVD risk
An AHA scientific statement aims to raise awareness of healthcare providers and women about the menopause transition as a time of increasing heart...
Guidelines
New guidelines address diabetes management in kidney disease
The Kidney Disease: Improving Global Outcomes synopsis document is aimed at primary care physicians and nonnephrology specialists, as well as...
Guidelines
First-of-its kind guideline on lipid monitoring in endocrine diseases
A new guideline from the Endocrine Society calls for heightened awareness of cholesterol management and treatment in endocrine diseases beyond...
Guidelines
New return-to-play recommendations for athletes with COVID-19
The American College of Cardiology’s Sports and Exercise Cardiology Section has updated its May 2020 recommendations on safe return to play among...
Guidelines
AHA scientific statement highlights cardiorenal benefit of new diabetes drugs
SGLT2 inhibitors and GLP-1 receptor agonists should be considered in people with type 2 diabetes and chronic kidney disease to protect against...
Conference Coverage
Many providers don’t follow hypertension guidelines
Most health care professionals rely on clinic BP measurements to make a new diagnosis of hypertension, and view pressure measured manually with a...